Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
作者: Briete GoortsThiemo J. A. van NijnattenLinda de MunckMartine MoossdorffEsther M. HeutsMaaike de BoerMarc B. I. LobbesMarjolein L. Smidt
作者单位: 1Maastricht University Medical Centre
2Netherlands Comprehensive Cancer Organisation (IKNL)
刊名: Breast Cancer Research and Treatment, 2017, Vol.163 (1), pp.83-91
来源数据库: Springer Nature Journal
DOI: 10.1007/s10549-017-4155-2
关键词: Breast cancerPathological complete responseNeoadjuvant chemotherapyTumor sizeSurvival
英文摘要: Pathological complete response (pCR) is the ultimate response in breast cancer patients treated with neoadjuvant chemotherapy (NCT). It might be a surrogate outcome for disease-free survival (DFS) and overall survival (OS). We studied the effect of clinical tumor stage (cT-stage) on tumor pCR and the effect of pCR per cT-stage on 5-year OS and DFS.
原始语种摘要: Pathological complete response (pCR) is the ultimate response in breast cancer patients treated with neoadjuvant chemotherapy (NCT). It might be a surrogate outcome for disease-free survival (DFS) and overall survival (OS). We studied the effect of clinical tumor stage (cT-stage) on tumor pCR and the effect of pCR per cT-stage on 5-year OS and DFS.
全文获取路径: Springer Nature  (合作)
分享到:
来源刊物:
影响因子:4.469 (2012)

×
关键词翻译
关键词翻译
  • chemotherapy 化学疗法
  • breast 胸部
  • pathological 病理学的
  • predictor 预示
  • stage 
  • response 响应
  • cancer 癌症
  • complete 实行
  • survival 生存
  • tumor 肿胀